-
-
-
-
-
-
-
Daxor Corporation Unveils Next-Gen BVA Analyzer
-
-
-
-
-
-
-
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
-
-
-
-
-
-
-
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
-
-
-
-
-
-
-
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
-
-
-
72,695 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

